Pravastatin does not alter protease inhibitor exposure or virologic efficacy during a 24-week period of therapy.
J Acquir Immune Defic Syndr
; 30(4): 460-2, 2002 Aug 01.
Article
in En
| MEDLINE
| ID: mdl-12138355
Search on Google
Collection:
01-internacional
Health context:
2_ODS3
Database:
MEDLINE
Main subject:
HIV Infections
/
Pravastatin
/
HIV Protease Inhibitors
/
Hypercholesterolemia
/
Anticholesteremic Agents
Type of study:
Clinical_trials
Limits:
Humans
/
Male
Language:
En
Journal:
J Acquir Immune Defic Syndr
Year:
2002
Document type:
Article